港股異動 | 恆騰網絡(0136.HK)大漲超15% 《你好,李煥英》票房突破49億
格隆匯3月3日丨恆騰網絡(0136.HK)午後大幅拉昇至15.5%,早盤一度跌超14%,大幅震盪34%。現報10.72港元,暫成交15.7億港元,總市值990億港元。據新浪電影,3月3日13時,電影《你好,李煥英》上映20天,累計票房突破49億。 恆騰網絡旗下儒意影業為《你好,李煥英》主要出品方和最大保底發行方。此前,儒意影業出品發行的影片《送你一朵小紅花》,累計票房超人民幣14.3億元,成為中國元旦票房冠軍。此外,截至1月末,旗下南瓜電影累計註冊會員3610.7萬人,付費訂閲用户592.7萬人。以中國版Netflix為定位的南瓜電影,是國內最大的會員訂閲制視頻平台。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.